Nanobiosym

📍 Cambridge, United States🗓 Founded 2004👥 11 employees💰 Last funded Jul 2020
🌐 nanobiosym.com
Website LinkedIn
Nanobiosym® (NBS) is an innovation engine dedicated to creating a new science that emerges from the holistic integration of physics, biomedicine, and nanotechnology. NBS focuses on incubating transformational technologies that have the potential for game-changing impact and commercializing and scaling up these technologies for deployment in developed and developing world markets. NBS leverages science and technology to address our planet’s greatest unmet needs in global health, energy and the environment. Nanobiosym® Diagnostics (NBSDx) focuses on the commercialization of its proprietary technology platform, that can rapidly and accurately detect genetic fingerprints from any biological organism, empowering people worldwide with rapid, affordable, and portable diagnostic information about their own health. To maximize global humanitarian impact, we have spearheaded the Nanobiosym Global Initiative, which is building innovative public-private partnerships with governments, NGO’s, academic, industrial and global thought leaders to help bring emerging technologies to address some of the world’s most pressing challenges.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2004
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Nanobiosym?
Nanobiosym has 1 investor on record on gritt.io.
When did Nanobiosym last raise funding?
The most recent investment in Nanobiosym recorded on gritt.io was in July 2020.
When was Nanobiosym founded?
Nanobiosym was founded in 2004.
What industry is Nanobiosym in?
Nanobiosym operates in Nanotechnology Research. Find similar Nanotechnology Research investors on gritt.io.
Where is Nanobiosym based?
Nanobiosym is headquartered in Cambridge, United States.